May 21, 2018 – Raleigh, NC

The MAA Laboratories team will attend the BIO 2018 convention on June 4-7 in Boston. For inquiries related to product licensing and development partnerships, or to arrange a meeting with MAA Laboratories, please contact our business development team at BD@maalaboratories.com.

For press and other inquiries, please contact:

Corporate Office
MAA Laboratories, Inc.
310 S. Harrington Street
Raleigh, NC 27601
Email: info@maalaboratories.com
Phone: 919.271.7868

January 2, 2018 – Raleigh, NC

The MAA Laboratories team will attend the 36^th annual JP Morgan Healthcare Conference on January 8 – 11 in San Francisco, California. For inquiries related to product licensing and development partnerships, or to arrange a meeting with MAA Laboratories, please contact our business development team at BD@maalaboratories.com.

For press and other inquiries, please contact:

Corporate Office
MAA Laboratories, Inc.
310 S. Harrington Street
Raleigh, NC 27601
Email: info@maalaboratories.com
Phone: 919.271.7868

September 19, 2017 – Raleigh, NC

MAA Laboratories has been awarded an NIH Phase I Small Business Innovation Research (SBIR) grant. Awarded via the National Cancer Institute, an institute of the NIH, the SBIR grant will provide non-dilutive funding to MAA Laboratories to develop a novel formulation of an anti-leukemia drug product, which currently has significant deficiencies related to dosing and bioavailability.The goal of the project is to use MAA’s proprietary NanoCont^TM technology to create an anti-leukemia drug product with markedly improve performance, which will provide an improved therapeutic option for patients with leukemia. 

August 30, 2017 – Raleigh, NC

MAA Laboratories has received a grant from the One N.C. Small Business Program. The award is based on the successful funding of MAA Laboratories’ Phase I SBIR grant from the National Science Foundation. The NSF SBIR grant was funded to further develop the company’s NanoCont^TM drug development technology. One N.C. matching funds will be used to accelerate the development of MAA Laboratories pipeline products through pre-clinical testing. 

June 1, 2017 – Raleigh, NC

MAA Laboratories has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Science Foundation. The SBIR grant will provide non-dilutive funding to MAA Laboratories to further develop the company’s NanoCont^TM drug development technology.